Rallybio Corp
RLYB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739410
No open-market purchases or sales by Rallybio Corp insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $65.0M in total; Viking Global Investors is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Rallybio Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 47 | 53 | +6 |
| Shares | 27.7M | 27.8M | +131.4K (+0.5%) |
| Value | $208.8M | $402.1M | +$193.3M (+92.6%) |
New holders (9)
Institutions that held Rallybio Corp at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CHI Advisors LLC | 194,297 | $2.81M | 0.76% |
| Dimensional Fund Advisors LP | 23,166 | $335.0K | 0.00% |
| Mariner, LLC | 20,571 | $298.0K | 0.00% |
| Northeast Financial Consultants Inc | 13,066 | $189.0K | 0.01% |
| MetLife Investment Management | 10,279 | $148.7K | 0.00% |
| Metropolitan Life Insurance Co | 1,166 | $16.9K | 0.00% |
| Allspring Global Investments Holdings, LLC | 1,028 | $14.0K | 0.00% |
| UBS Group AG | 868 | $13.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 301 | $4.00K | 0.00% |
Sold out (3)
Institutions that held Rallybio Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Millennium Management LLC | 18,195 | $137.0K |
| Acadian Asset Management LLC | 10,188 | $77.0K |
| Mercer Global Advisors Inc | 10,000 | $76.0K |